Medscape Disrupts Medical AI with Industry-First Trusted Medical Intelligence Powering Clinical Precision for 13+ Million HCPs Globally November 19, 2025 Codeveloped with clinicians, Medscape AI is the first and only advanced AI reference tool powered by three decades of Medscape expertise, peer-reviewed literature, and real-time news insights – empowering HCPs globally with fast, accurate, and trustworthy medical insights.
AGC Biologics and Repair Biotechnologies Partner on Novel mRNA Therapeutic to Combat the Leading Cause of Human Mortality November 19, 2025 Partnership leverages AGC Biologics’ cost-effective and dependable cGMP mRNA and LNP capabilities
When Regulation and AI Converge: SymphonyAI Joins the FCA Supercharged Sandbox to Pioneer Responsible Fintech Innovation November 19, 2025 SymphonyAI joins the FCA’s new Supercharged Sandbox to advance explainable, responsible AI innovation for UK financial services
Palantir and PwC UK Sign a Multi-Year, Multi-Million-Pound Deal to Accelerate AI Transformation as Preferred Partners in the UK November 19, 2025 The renewed alliance reflects the continued relationship between PwC and Palantir, bringing together deep industry expertise and cutting-edge AI platforms to deliver transformational results for clients and stakeholders.
Schneider Electric and Bloomberg New Economy Launch Energy Technology Coalition to Unlock the Future of ‘Smart Demand’ November 19, 2025 Schneider Electric, a global energy technology leader, and Bloomberg New Economy announced today the launch of the Energy Technology Coalition (‘Coalition’). This new private sector initiative brings together global decision makers and experts across industries to accelerate the adoption of technologies that make energy consumption more efficient, resilient, and responsive amid soaring global electricity demand. [...]
Reply at Microsoft Ignite 2025: Showcasing AI Innovation, Copilot Experiences, and Intelligent Enterprise Solutions November 18, 2025 Reply [EXM, STAR: REY] is taking part in Microsoft Ignite 2025, a premier event for technology professionals and decision-makers hosted by Microsoft, held from November 18 to 21 in San Francisco, California. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251118836834/en/ A trusted Microsoft partner since 1996, Reply empowers organizations to innovate with [...]
Interactive Brokers Expands Global Market Access with the Taipei Exchange November 18, 2025 Interactive Brokers (Nasdaq: IBKR), an automated global electronic broker, announced access to the Taipei Exchange (TPEx), further expanding its global reach. Eligible clients of Interactive Brokers can now trade equities, ETFs, and Taiwan Depositary Receipts (TDRs) listed on TPEx, alongside products from over 160 global exchanges from a single platform. This extends the opportunity set [...]
Artec 3D Launches Artec Studio Lite: Professional 3D Capture for Everyone November 18, 2025 Global 3D scanning leader Artec 3D has launched a new, accessible version of its software, Artec Studio Lite. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251118804372/en/ Designed to make Artec Studio’s professional 3D tools available to a larger audience, Artec Studio Lite pairs cutting-edge AI Photogrammetry with advanced 3D processing and analysis, [...]
ShipStation® Improves Fulfilment Efficiency for UK Businesses With Enhanced Platform Capabilities November 18, 2025 UK merchants can now seamlessly manage shipping operations with new inventory and analytics solutions, flexible plans including a free option, and product advancements
European Commission Grants Approval of Remsima™ IV Liquid Formulation, World’s First Liquid Formulation of IV Infliximab November 18, 2025 Remsima™ IV (intravenous) liquid formulation, the world’s first liquid formulation of IV infliximab has been approved by the European Commission (EC) for all previously approved indications for Remsima™ IV powder formulation1 The approval is based on the comparability data between infliximab powder formulation and the liquid formulation2 The new liquid formulation of infliximab, available in 100 mg and a newly introduced 350 mg presentation, eliminates the need for reconstitution and cuts drug preparation time by 51%, lowering preparation costs by 20% 1,3 Projected annual cost savings across seven European countries could reach up to €2.6 million, alongside significant improvements to workflow efficiency 3